Profil
Christian Pradeyrol is the founder of Imaxio SA, a company founded in 2000, where he holds the title of Chairman & Chief Executive Officer.
He is currently working as a Director at Osivax SAS and as a Managing Partner at Pradeyrol Développement.
Postes actifs de Christian Pradeyrol
| Sociétés | Poste | Début |
|---|---|---|
Imaxio SA
 Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Directeur Général | 01/01/2000 |
Pradeyrol Développement
 Pradeyrol Développement Financial ConglomeratesFinance Pradeyrol Développement SC operates as an investment holding company. It invests in the biotechnology sector and mainly on molecular diagnostics. The company was founded on August 16, 2007 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Osivax SAS
 Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Health Technology |
Pradeyrol Développement
Pradeyrol Développement Financial ConglomeratesFinance Pradeyrol Développement SC operates as an investment holding company. It invests in the biotechnology sector and mainly on molecular diagnostics. The company was founded on August 16, 2007 and is headquartered in Paris, France. | Finance |
Osivax SAS
Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France. | Health Technology |
